Gérard Lizard is an INSA-Lyon biochemist and engineer with a PhD in Molecular and Cellular Biology and a PhD in Human Biology. Gérard Lizard has been a postdoctoral researcher in the pharmaceutical industry from 1984 to 1991. He was recruited by Inserm in 1991. He was one of the first researchers to work on cell death by apoptosis in atherosclerosis. This led him to demonstrate that certain oxidized derivatives of cholesterol (called oxysterols, especially 7-ketocholesterol and 7-beta-hydroxycholesterol), which are major constituents of oxidized lipoproteins, induce a mode of cell death by oxiapoptophagy (oxidative stress, apoptosis, and autophagy). Since 7-ketocholesterol and 7-beta-hydroxycholesterol are also identified at increased concentrations in patients with cardiovascular diseases, the retina of patients with age-related macular degeneration, the cortex of Alzheimer's patients, and the plasma of sarcopenic patients, Gérard LIZARD has gradually oriented his research on aging and the pathophysiology of age-related diseases by focusing on the lipotoxicity of oxysterols and the impact on mitochondria and peroxisomes. Gérard Lizard has supervised 20 doctoral, 20 master's, and 3 post-doctoral theses and contributed to around 30 clinical studies. He is currently the author of 270 publications and several books. Since 2012, he has been director of the Biochemistry Laboratory "Peroxisome, Inflammation, and Lipid Metabolism" from the University de Bourgogne (Dijon, France).
Gérard Lizard is an INSA-Lyon biochemist and engineer with a PhD in Molecular and Cellular Biology and a PhD in Human Biology. Gérard Lizard has been a postdoctoral researcher in the pharmaceutical industry from 1984 to 1991. He was recruited by Inserm in 1991. He was one of the first researchers to work on cell death by apoptosis in atherosclerosis. This led him to demonstrate that certain oxidized derivatives of cholesterol (called oxysterols, especially 7-ketocholesterol and 7-beta-hydroxycholesterol), which are major constituents of oxidized lipoproteins, induce a mode of cell death by oxiapoptophagy (oxidative stress, apoptosis, and autophagy). Since 7-ketocholesterol and 7-beta-hydroxycholesterol are also identified at increased concentrations in patients with cardiovascular diseases, the retina of patients with age-related macular degeneration, the cortex of Alzheimer's patients, and the plasma of sarcopenic patients, Gérard LIZARD has gradually oriented his research on aging and the pathophysiology of age-related diseases by focusing on the lipotoxicity of oxysterols and the impact on mitochondria and peroxisomes. Gérard Lizard has supervised 20 doctoral, 20 master's, and 3 post-doctoral theses and contributed to around 30 clinical studies. He is currently the author of 270 publications and several books. Since 2012, he has been director of the Biochemistry Laboratory "Peroxisome, Inflammation, and Lipid Metabolism" from the University de Bourgogne (Dijon, France).